coronaviru
diseas
outbreak
ongo
global
health
emerg
pathogenesi
remain
unclear
reveal
blood
cell
immun
respons
profil
use
mrna
tcr
bcr
v
j
transcriptom
analysi
singlecel
resolut
data
pbmc
tcr
bcr
clone
obtain
blood
cell
subtyp
new
cell
marker
gene
identifi
particip
number
specif
subtyp
immun
cell
chang
significantli
compar
patient
control
activ
interferonmapk
pathway
major
defens
mechan
mapk
transcript
signal
inhibit
cure
patient
tcr
bcr
v
j
recombin
highli
divers
gener
differ
antibodi
therefor
interferonmapk
pathway
tcrand
bcrproduc
antibodi
play
import
role
immun
respons
immun
defici
immun
overrespons
may
result
condit
patient
becom
critic
sever
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
battl
human
pathogen
virus
never
end
epidem
diseas
includ
zika
sever
acut
respitatori
sundrom
sar
ebola
strike
quickli
often
kill
hundr
peopl
singl
outbreak
decemb
novel
coronaviru
belong
orthocoronavirina
subfamili
distinct
middl
east
respiratori
syndrom
mer
cov
sarscov
emerg
wuhan
china
rapid
persontoperson
spread
caus
coronaviru
diseas
covid
present
immin
threat
public
health
caus
global
health
emerg
world
health
organ
emerg
committe
declar
outbreak
public
health
emerg
intern
concern
mortal
rate
persontoperson
transmiss
march
peopl
fallen
ill
lead
death
countri
coronaviru
continu
spread
quickli
world
symptom
includ
fever
myalgia
fatigu
well
dri
cough
short
breath
sputum
product
headach
hemoptysi
sore
throat
diarrhea
lymphopenia
prolong
prothrombin
time
elev
lactat
dehydrogenas
level
also
observ
patient
comput
tomographi
ct
identifi
bilater
patchi
shadow
ground
glass
opac
lung
despit
high
infect
mortal
rate
specif
cure
diseas
pathogenesi
remain
unclear
human
adapt
immun
system
play
critic
role
defend
viral
infect
mani
immun
cell
leukocyt
immun
molecul
specif
plasma
protein
intrins
compon
blood
therefor
function
blood
immun
system
insepar
cell
b
cell
import
pathogenesi
manyperhap
allimmunemedi
diseas
cell
receptor
tcr
mediat
recognit
pathogenassoci
epitop
interact
peptid
major
histocompat
complex
pmhc
tcr
b
cell
receptor
bcr
gener
genom
rearrang
germlin
level
process
term
v
j
recombin
abil
gener
mark
divers
among
tcr
bcr
parameter
element
antigenspecif
immun
repertoir
across
divers
set
epitop
may
gener
power
applic
varieti
research
field
diagnosi
treatment
infecti
diseas
focu
insight
blood
immun
respons
use
mrna
tcr
bcr
v
j
recombin
analysi
singlecel
resolut
studi
particip
recruit
sichuan
provinc
china
basic
inform
clinic
featur
patient
list
tabl
lung
ct
imag
subject
shown
fig
one
critic
case
patient
male
year
old
one
sever
case
patient
male
year
old
six
moder
case
patient
compris
two
male
four
femal
age
year
old
tabl
two
cure
patient
patient
male
year
old
patient
femal
year
old
discharg
day
hospit
test
neg
diseas
sign
disappear
three
healthi
peopl
includ
normal
control
nc
tabl
order
differenti
immun
respons
infecti
diseas
therebi
identifi
uniqu
immun
respons
also
recruit
one
case
influenza
patient
one
case
acut
pharyng
patient
one
case
cerebr
infarct
patient
control
tabl
peripher
blood
mononuclear
cell
pbmc
individu
isol
whole
blood
singlecel
mrna
sequenc
scrnaseq
analysi
pbmc
perform
x
genom
platform
chromium
next
gem
singl
cell
v
j
reagent
kit
fig
qualiti
control
obtain
pbmc
cell
tcr
clone
bcr
clone
sampl
sampl
identifi
complet
differ
pbmc
cell
type
could
divid
cell
subtyp
accord
marker
gene
cell
fig
tabl
cell
type
includ
cell
identifi
ltb
marker
cell
identifi
dendrit
cell
identifi
cytotox
cell
identifi
cytotox
cell
identifi
cell
type
fig
tabl
suggest
human
pbmc
evolv
highli
differenti
cell
subtyp
resist
invas
pathogen
three
main
state
analysi
process
reconstruct
development
trajectori
cell
subtyp
show
continu
trajectori
differenti
pbmc
fig
fig
addit
total
new
candid
marker
gene
link
cell
subtyp
identifi
fig
suggest
potenti
role
newli
discov
cell
marker
identif
function
studi
subtyp
investig
immun
cell
behavior
cell
subtyp
differ
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
analyz
gene
express
differ
cell
subtyp
condit
control
identifi
number
differenti
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
express
de
gene
extern
databas
explor
enrich
signal
pathway
de
gene
cell
subtyp
analyz
enrich
pathway
de
gene
cell
cluster
use
local
string
network
analysi
patient
critic
sever
moder
cure
condit
found
sever
condit
patient
signal
pathway
significantli
chang
half
cell
subtyp
compar
normal
control
among
pathway
import
overactiv
interferonrel
signal
pathway
includ
synthas
type
interferon
signal
pathway
naiv
cell
cell
cell
interferon
alphabetagamma
signal
naiv
cell
cell
cell
fig
tabl
condit
interferon
signal
also
overactiv
vari
degre
howev
cure
patient
interferon
signal
mildli
activ
compar
patient
sever
moder
condit
cure
condit
signal
pathway
relat
mrna
translat
viru
suppress
signal
pathway
relat
mapk
significantli
enrich
fig
tabl
detect
whether
signal
pathway
chang
specif
compar
patient
patient
influenza
patient
acut
pharyng
patient
cerebr
infarct
patient
found
signal
pathway
still
enrich
filter
relat
diseas
control
fig
among
pathway
interferonmapk
signal
pathway
major
blood
immun
respons
infect
activ
mapk
signal
pathway
interferon
involv
set
defens
mechan
evolv
human
be
fight
viral
infect
explor
express
differ
gene
involv
differ
cell
type
variou
condit
analyz
gene
express
patient
compar
control
fig
fig
first
observ
upregul
express
interferon
signal
gene
patient
among
interferon
protein
origin
known
involv
innat
immun
interven
cell
prolifer
increasingli
express
mani
cell
type
includ
dendrit
cell
tabl
gene
previous
shown
regul
cell
invas
migrat
prolifer
innat
immun
inhibit
proinflammatori
cytokin
product
three
group
inpati
differ
condit
upregul
express
gene
observ
dendrit
cell
cell
dendrit
cell
cytotox
cell
plasmacytoid
dendrit
cell
interestingli
contrast
three
group
inpati
express
pattern
gene
two
cure
patient
opposit
cure
patient
downregul
express
detect
indic
mapk
signal
pathway
inhibit
cell
result
indic
downregul
mapk
signal
pathway
may
one
sign
patient
recoveri
explor
antibodi
clonal
prolifer
tcr
bcr
conduct
tcr
bcr
v
j
singl
cell
transcriptom
analysi
use
integr
analysi
detect
tcr
cell
clone
bcr
clone
subject
fig
result
reveal
antibodi
repertoir
patient
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
critic
condit
patient
fewest
tcr
clone
detect
sever
condit
patient
tcr
clone
detect
one
moder
patient
patient
tcr
clone
detect
accord
find
fewer
tcr
clone
sever
condit
distribut
tcr
clone
number
tcr
clone
patient
shown
fig
tabl
use
evolutionari
analysi
top
tcr
antibodi
sequenc
reveal
tcr
sequenc
found
sequenc
cassegvgtpfdeqff
patient
casslglagdldeqff
casnqglaggrlyneqff
patient
cassqergvyneqff
patient
cassevwasdheqyf
patient
close
relat
fig
suggest
antibodi
sequenc
may
special
activ
influenza
compar
tcr
number
bcr
clone
detect
much
lower
fig
tabl
howev
strong
bcr
antibodi
induc
patient
except
two
moder
patient
patient
one
moder
patient
patient
fig
detect
clone
iglorkigh
sequenc
cqqygsspwtfcarvaesyydfwsakwegafdiw
clone
cqqynsysfcarsgpitifgvvikgrggdafdiw
fig
tabl
anoth
moder
patient
patient
four
high
frequenc
clone
identifi
includ
cqqyysipsltfcathrtyfdwllpfdyw
fig
tabl
result
suggest
antibodi
produc
patient
may
specif
affin
analyz
top
tcr
encod
antibodi
sequenc
known
antigen
annot
vdjdb
antigen
categori
databas
fig
patient
detect
immun
respons
known
antigen
includ
epsteinbarr
viru
ebv
influenza
yellow
fever
rna
virus
well
dna
virus
cytomegaloviru
cmv
addit
autoantigen
detect
sever
condit
patient
moder
condit
patient
patient
autoantigen
respons
obviou
activ
indic
sever
diseas
condit
may
relat
strong
autoimmun
contrari
critic
condit
patient
two
antibodi
ebola
ebv
antigen
detect
result
suggest
critic
condit
may
caus
insuffici
immun
sever
condit
may
aggrav
excess
autoimmun
normal
condit
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
immun
respons
antigen
detect
nc
nc
nc
two
antigen
detect
influenza
fig
patient
influenza
patient
antigen
autoimmun
respons
yellow
fever
viru
detect
patient
acut
pharyng
patient
ebv
influenza
yellow
fever
viru
antigen
detect
autoimmun
respons
patient
cerebr
infarct
patient
known
antigen
detect
result
indic
human
might
use
known
immun
recognit
mainli
known
rna
virus
fight
type
interferon
ifni
crucial
promot
antivir
defens
induct
antivir
effector
studi
singl
cell
transcriptom
result
show
upregul
time
critic
patient
time
sever
patient
time
moder
patient
time
mild
patient
time
cure
patient
compar
normal
control
fig
result
suggest
candid
marker
gene
infect
previous
shown
play
role
prebcel
growth
also
show
upexpress
patient
consist
singl
cell
transcript
data
express
profil
fo
transcript
factor
mediat
mapk
pathway
signal
show
upregul
patient
downregul
cure
patient
result
suggest
fo
candid
marker
gene
cure
patient
perform
pbmc
immunofluoresc
test
compar
protein
express
patient
control
immunofluoresc
stain
show
highli
express
whole
lymphocyt
patient
partial
express
lymphocyt
control
fig
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
summari
demonstr
enter
blood
circulatori
system
caus
blood
immun
respons
infect
respiratori
system
therefor
patient
damag
relat
multipl
organ
leukocyt
immun
respons
involv
mani
cell
subtyp
includ
cell
cytotox
cell
cell
cytotox
cell
dendrit
cell
cell
subtyp
viru
reach
blood
immun
cell
might
replicatemainli
dendrit
cell
cell
naiv
cell
might
activ
multipl
cell
subtyp
interferon
signal
pathway
produc
effector
fight
viru
similar
process
also
happen
influenza
west
nile
viru
infect
human
downstream
activ
mapk
express
downstream
effector
activ
key
transcript
factor
fo
jun
junb
lead
wide
rang
antivir
respons
blood
system
fig
result
suggest
immun
respons
may
come
back
normal
situat
patient
recoveri
mapk
signal
thu
inhibit
conclus
studi
reveal
immun
respons
process
enter
blood
circul
system
use
immun
profil
analysi
singlecel
resolut
critic
condit
number
differ
cell
type
express
gene
tcrbcr
respons
indic
relationship
critic
natur
patient
condit
immunodefici
contrari
sever
condit
shown
relat
strong
autoimmun
respons
overactiv
interferon
pathway
result
suggest
immun
defici
immun
overreact
may
make
patient
go
wors
condit
imbal
adapt
immun
respons
studi
also
show
activ
interferonmapk
signal
pathway
tcrand
bcrproduc
antibodi
play
key
role
combat
infect
result
provid
import
inform
treatment
drug
develop
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
supplementari
materi
lgl
e
igk
tabl
clinic
blood
routin
test
inform
particip
analyz
use
v
j
transcriptom
analysi
tabl
list
known
marker
gene
new
marker
gene
highli
express
gene
cell
sub
group
identifi
integr
analysi
sequenc
sampl
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
tabl
differenti
express
interferonrel
gene
cell
sub
type
patient
compar
normal
control
tabl
differenti
express
mapk
signal
gene
cell
sub
type
patient
compar
normal
control
tabl
list
enrich
clone
antibodi
patient
use
tcr
singl
cell
transcriptom
analysi
tabl
list
enrich
clone
antibodi
patient
use
bcr
singl
cell
transcriptom
analysi
extern
databas
differenti
express
gene
cell
subtyp
critic
patient
normal
control
extern
databas
differenti
express
gene
cell
subtyp
sever
patient
normal
control
extern
databas
differenti
express
gene
cell
subtyp
moder
patient
normal
control
extern
databas
differenti
express
gene
cell
subtyp
cure
patient
normal
control
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
fo
upregul
hospit
patient
downregul
cure
patient
b
immunofluoresc
stain
pbmc
patient
normal
control
c
respons
blood
system
viru
reach
blood
immun
cell
activ
multipl
cell
subtyp
interferon
signal
pathway
produc
effector
fight
viru
downstream
activ
mapk
express
downstream
effector
activ
key
transcript
factor
fo
jun
junb
lead
wide
rang
antivir
respons
blood
system
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
